{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:14:41Z","timestamp":1780910081921,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.neuint.2026.106177","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:05:29Z","timestamp":1778735129000},"page":"106177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Parkinson's disease as a disorder of synaptic raft integrity: A unified explanation for motor subtypes and non-motor symptoms"],"prefix":"10.1016","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8148-6326","authenticated-orcid":false,"given":"Saburo","family":"Sakoda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2026.106177_bib1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mds.25729","article-title":"Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease","volume":"29","author":"Abbott","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2026.106177_bib2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrn2059","article-title":"Lipid raft microdomains and neurotransmitter signalling","volume":"8","author":"Allen","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2026.106177_bib3","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1038\/emboj.2012.202","article-title":"Mitochondria-associated ER membranes in neurodegeneration","volume":"31","author":"Area-Gomez","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.neuint.2026.106177_bib4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson's disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2026.106177_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2026.106177_bib6","article-title":"Lipid pathway alterations in Parkinson's disease primary visual cortex","volume":"6","author":"Cheng","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2026.106177_bib7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nn.2781","article-title":"Flotillin-1 and dopamine transporter microdomain localization","volume":"14","author":"Cremona","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2026.106177_bib8","first-page":"867","article-title":"Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences","volume":"122","author":"Exner","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2026.106177_bib9","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2119\/molmed.2011.00119","article-title":"Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease","volume":"17","author":"Fabelo","year":"2011","journal-title":"Mol. Med."},{"key":"10.1016\/j.neuint.2026.106177_bib10","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1471-4159.2008.05262.x","article-title":"Phorbol ester-induced regulation of dopamine transporter associated with membrane rafts","volume":"105","author":"Foster","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2026.106177_bib11","article-title":"Lipid dysregulation in Parkinson's disease: a lipidomics perspective","volume":"85","author":"Galper","year":"2022","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.neuint.2026.106177_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3233\/JPD-171103","article-title":"The role of lipids interacting with \u03b1-synuclein in the pathogenesis of Parkinson's disease","volume":"7","author":"Galvagnion","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.neuint.2026.106177_bib13","first-page":"11327","article-title":"Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of \u03b1-synuclein","volume":"112","author":"Galvagnion","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuint.2026.106177_bib14","first-page":"150","article-title":"Metabolomics studies in Parkinson's disease: advances and perspectives","volume":"12","author":"Gonz\u00e1lez-Riano","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.neuint.2026.106177_bib15","first-page":"153","article-title":"Lipid and immune abnormalities in Parkinson's disease","volume":"9","author":"Hallett","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuint.2026.106177_bib17","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2026.106177_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-65489-2","article-title":"Multi-omic analysis reveals lipid dysregulation associated with mitochondrial dysfunction in Parkinson's disease brain","volume":"16","author":"H\u00e4llqvist","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuint.2026.106177_bib18","first-page":"337","article-title":"RDW in Parkinson's disease","volume":"41","author":"Kenangil","year":"2020","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.neuint.2026.106177_bib19","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008888","article-title":"Genetics of Parkinson's disease","volume":"2","author":"Klein","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.neuint.2026.106177_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2741\/4308","article-title":"Lipid rafts involvement in the pathogenesis of Parkinson's disease","volume":"20","author":"Kubo","year":"2015","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"10.1016\/j.neuint.2026.106177_bib21","first-page":"1","article-title":"Lipid rafts and erythrocyte membranes","volume":"1862","author":"Leonard","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuint.2026.106177_bib22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1126\/science.1174621","article-title":"Lipid rafts as a membrane-organizing principle","volume":"327","author":"Lingwood","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neuint.2026.106177_bib23","article-title":"Improvement of blood plasmalogens and clinical symptoms in Parkinson's disease by oral administration of ether phospholipids: a preliminary report","volume":"2020","author":"Mawatari","year":"2020","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.neuint.2026.106177_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2026.106177_bib25","first-page":"3036","article-title":"Lipid raft-dependent signaling controls dopamine transporter function","volume":"20","author":"Prou","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.neuint.2026.106177_bib26","article-title":"Parkinson's disease as a lipid raft disorder (raftopathy): a unifying hypothesis","author":"Sakoda","year":"2026","journal-title":"Zenodo"},{"key":"10.1016\/j.neuint.2026.106177_bib27","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2026.106177_bib28","first-page":"451","article-title":"RBC deformability in Parkinson's disease","volume":"74","author":"Sato","year":"2020","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.neuint.2026.106177_bib29","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2026.106177_bib30","first-page":"138","article-title":"GM1 ganglioside in Parkinson's disease: results of a five-year open study","volume":"324","author":"Schneider","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuint.2026.106177_bib31","first-page":"623","article-title":"Deficiency of ganglioside GM1 in Parkinson's disease","volume":"78","author":"Schneider","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2026.106177_bib32","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuint.2026.106177_bib33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/42408","article-title":"Functional rafts in cell membranes","volume":"387","author":"Simons","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2026.106177_bib34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2026.106177_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neulet.2015.05.030","article-title":"\u03b1-Synuclein oligomers in RBCs","volume":"599","author":"Wang","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2026.106177_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"\u03b1-Synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies","volume":"23","author":"Wong","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2026.106177_bib37","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/jnr.23090","article-title":"Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans","volume":"90","author":"Wu","year":"2012","journal-title":"J. Neurosci. Res."},{"issue":"14","key":"10.1016\/j.neuint.2026.106177_bib38","article-title":"Lipid and transcriptional regulation in a Parkinson's disease mouse model by intranasal vesicular and hexosomal plasmalogen-based nanomedicines","volume":"13","author":"Wu","year":"2024","journal-title":"Adv. Healthcare Mater."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018626000689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018626000689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:53:18Z","timestamp":1780908798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018626000689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":38,"alternative-id":["S0197018626000689"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2026.106177","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parkinson's disease as a disorder of synaptic raft integrity: A unified explanation for motor subtypes and non-motor symptoms","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2026.106177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106177"}}